e-Drug3D 435 |
DANAZOL
|
cas 17230-88-5 |
CLASS GENITO |
ROUTE (list) ORAL |
ATC code |
PK parameters Tmax 4 HOUR Solubility INSOLUBLE IN WATER |
Target TARGET ESTROGEN RECEPTOR PROGESTERONE RECEPTOR ANDROGEN RECEPTOR PDB Ligand code = QA1 (link to the list of PDB complexes) Download experimental 3D coordinates of QA1 with added hydrogens |
DrugCentral Androgen receptor UNIPROT P10275 AR Progesterone receptor UNIPROT P06401 PGR |
Download SDF file | Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol, (17.alpha.)- Formula: Calculated chemical properties: MW 337.45 NB_atoms 25 XLogP 4.22 PSA 42.721 NB_HD 1 NB_HA 3 fsp3 0.68 Lipinski(0=no;1=yes) 1 |
FDA NDA 071569 (pdf not found) INN (DANAZOL) DANAZOL (AM THERAP) APPROVAL= - YEAR= 0 DISCONTINUED NDA 017557 (label) INN (DANAZOL) DANOCRINE (SANOFI AVENTIS US) APPROVAL= AP YEAR= 1976 DISCONTINUED NDA 074582 (pdf not found) INN (DANAZOL) DANAZOL (BARR) APPROVAL= AP YEAR= 1996 NDA 077246 (pdf not found) INN (DANAZOL) DANAZOL (LANNETT CO INC) APPROVAL= AP YEAR= 2005 NDA 078214 (pdf not found) INN (DANAZOL) DANAZOL (LANNETT) APPROVAL= AP YEAR= 2007 |
Other links: |